Live Breaking News & Updates on Pulmonary Hypertension Screening

Credit: Michigan medicine
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate.
Researchers at Michigan Medicine found that an internet application improved their ability to spot pulmonary arterial hypertension in patients with systemic sclerosis, or scleroderma. The unpredictable condition is marked by tightening of the skin that can damage internal organs.
The algorithm, aptly named DETECT, outperformed standard methods used to identify the form of high blood pressure in the lungs that causes the heart to weaken and fail.
We ve been advocating for a long time that every scleroderma patient should be screened on an annual basis using DETECT, and this data supports that, says Dinesh Khanna, M.B.B.S., M.Sc., senior author of the study and director of Michigan Medicine s Scleroderma Program. Pulmonary arterial hypertension is a leading cause of death for the ....

United States , Amber Young , Tanabe Pharma , Dinesh Khanna , Genentech Roche , Michigan Medicine Scleroderma Program , National Institute Of Arthritis , Boehringer Ingelheim , Eicos Sciences Inc , Michigan Medicine , Pulmonary Hypertension Screening , Systemic Sclerosis Cohort , National Institute , Skin Diseases , Blade Therapeutics , Mitsubishi Tanabe Pharma , United Therapeutics , Chief Medical Officer , Eicos Sciences , ஒன்றுபட்டது மாநிலங்களில் , அம்பர் இளம் , தனபெ பார்மா , தினேஷ் கண்ணா , ஜெநிஂடெக் ரோச் , மிச்சிகன் மருந்து ஸ்க்லரோடெர்மா ப்ரோக்ர்யாம் , தேசிய நிறுவனம் ஆஃப் கீல்வாதம் ,